NEWS

Press Releases

Human Longevity, Inc. and Venter Institute Scientists Publish Paper Demonstrating Inconsistency in Microbiome Studies due to Variable Approaches to DNA Sequencing and Data Analysis

Comparison of four common library prep methods found significant differences in types of microbes uncovered and showed biases in error and duplication rates

(SAN DIEGO, CA)—October 26, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that its researchers along with those from the J. Craig Venter Institute and the University of California, San Diego, have published a paper in the journal, Proceedings of the National Academy of Sciences (PNAS), outlining the confusing and conflicting microbiome results generated by a variety of next generation sequencing technology. They also outline recommendations for new research community standards in the microbiome research field given these differences. The paper is being published this week in the early online edition of PNAS.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Launches the Health Nucleus, a Comprehensive and Personalized Health Platform for Individuals

(SAN DIEGO, CA) OCTOBER 13, 2015 – Human Longevity, Inc. (HLI), the genomics-based, technology-driven company working to revolutionize the practice of medicine, announced today the launch of the company’s first Health Nucleus™, a genomic powered clinical research project that has the potential to transform healthcare. The inaugural Health Nucleus is located in San Diego, CA, at HLI’s headquarters facility. More Health Nucleus facilities are slated to open in 2016 in other US and International cities.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Appoints William A. Roper, Jr. as Chief Financial Officer

(SAN DIEGO, CA) September 28, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that William A. Roper, Jr. has been appointed Chief Financial Officer, reporting directly to HLI’s CEO, J. Craig Venter, Ph.D. Roper joins the company full-time after serving as interim CFO.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. and Discovery Ltd to Offer Whole Exome, Whole Genome and Cancer Genome Sequencing to Discovery Insurance Clients in South Africa and the United Kingdom

HLI Introduces a Whole Exome Sequencing Product for $250 USD

(SAN DIEGO, CA and SANDTON, SOUTH AFRICA)—September 22, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, and Discovery Ltd, a pioneering insurer dedicated to making people healthier, announced today that the two companies have entered into a multi-year agreement to offer whole exome, whole genome and cancer genome sequencing to Discovery’s clients in South Africa and the United Kingdom.
(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Hires Life Sciences Leader, Mark Winham, as Chief Operating Officer

(SAN DIEGO, CA) August 25, 2015—Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today that Mark A. Winham has joined the company as Chief Operating Officer. Winham, who brings more than 25 years of life sciences, medical operations and technical experience, will report directly to HLI’s CEO, J. Craig Venter, Ph.D. (more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Announces Kurt Oreshack as General Counsel

(SAN DIEGO, CA) July 8, 2015—Human Longevity, Inc. (HLI), the genomics based, technology driven company, announced today that Kurt Oreshack has been hired as General Counsel.  With degrees in law and philosophy with a focus on medical ethics, Oreshack brings years of experience as a corporate and securities attorney to help guide HLI’s pioneering healthcare work.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Announces Research Fellows Program

Program Gives Experts from Several Disciplines Unique Opportunity to Advance Human Genomic Understanding

Application Deadline is September 1, 2015

LA JOLLA, CA – Human Longevity, Inc. (HLI), the genomics-based, technology-driven company, announced today the HLI Research Fellows Program, designed to engage experts in the fields of genomics, informatics/bioinformatics, and machine learning to explore the latest findings and knowledge on genetics with clinically relevant outcomes.  The program gives scholars a unique opportunity to participate in innovative analysis of large scale genome data and to work with groups of scientists, bioinformaticians and machine learning specialists to ensure state-of-the-art annotation and interpretation of the human genome.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. and Cleveland Clinic Establish Broad Collaboration in Human Genomics

Initial work will focus on Cleveland Clinic GeneBank study

(LA JOLLA, CA and CLEVELAND, OH) May 14, 2015—Human Longevity, Inc. (HLI) and Cleveland Clinic today announced a broad collaboration agreement to first sequence and analyze blood samples from Cleveland Clinic’s GeneBank study of de-identified patients.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Receives CLIA Certification

(SAN DIEGO, CA) April 28, 2015 – Human Longevity, Inc. (HLI), the genomic-driven health information technology company, today announced that the company has received certification under the Clinical Laboratory Improvement Amendments of 1988 (CLIA). Under the “deemed status” provision of the U.S. Department of Health and Human Services’ (HHS) Center for Medicare and Medicaid Services (CMS), the state of California has granted the company’s initial CLIA clinical laboratory license.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets

NEWS

Press Releases

Human Longevity, Inc. Signs Agreement with Genentech for Whole Genome Sequencing and Analysis of Samples

(LA JOLLA, CA) January 14, 2015—Human Longevity, Inc. (HLI), the human health information technology and health care company, today announced a multi-year agreement with Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), to conduct whole genome sequencing of tens of thousands of de-identified samples from Genentech. HLI, using proprietary tools and unique expertise, will sequence genomes to 30x coverage and analyze the data. Financial details of the agreement were not disclosed.

(more…)

Media Contact

Heather Kowalski
hkowalski@humanlongevity.com
858-361-0466

Media Resources

HLI Fact Sheet
HLI FAQ

Tweets